Indane amine derivative, and preparation method and application thereof
A technology of indane amine and compound is applied in the field of indane amine derivatives, which can solve the problems of poor cell metabolism and inconvenient clinical use, and achieve the effects of good selectivity, good inhibitory activity, and good metabolic stability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0160] Example 1: N-hydroxy-2-((2,3-dihydro-1H-inden-1-yl)amino)pyrimidine-5-carboxamide
[0161]
[0162] Step 1: Synthesis of ethyl 2-((2,3-dihydro-1H-inden-1-yl)amino)pyrimidine-5-carboxylate
[0163] Ethyl 2-chloropyrimidine-5-carboxylate (200mg, 1.07mmol) and 1-aminoindan (214mg, 1.61mmol) were dissolved in 1,4-dioxane (3ml). Under ice-cooling, triethylamine (326 mg, 3.22 mmol) was added dropwise to the reaction mixture. After the dropwise addition, the reaction mixture was stirred at room temperature for 2 hours. The organic solvent was removed by concentration under reduced pressure, and methanol (2 ml) was added. After filtration, the filter cake was dried under reduced pressure to obtain the target compound (174 mg, yield 57.3%, white solid). LC-MS(ESI)m / z[M+H] + 284.2.
[0164] Step 2: Synthesis of N-hydroxy-2-((2,3-dihydro-1H-inden-1-yl)amino)pyrimidine-5-carboxamide
[0165] Dissolve ethyl 2-((2,3-dihydro-1H-inden-1-yl)amino)pyrimidine-5-carboxylate (100mg...
Embodiment 2
[0166] Example 2: N-Hydroxy-2-((1,2,3,4-tetrahydronaphthalen-1-yl)amino)pyrimidine-5-carboxamide
[0167]
[0168] Step 1: Synthesis of ethyl 2-((1,2,3,4-tetrahydronaphthalen-1-yl)amino)pyrimidine-5-carboxylate
[0169] Ethyl 2-chloropyrimidine-5-carboxylate (100mg, 0.537mmol), 1,2,3,4-tetralin-1-amine (79.0mg, 0.537mmol) and potassium carbonate (222mg, 1.612mmol) Add to N,N-dimethylformamide (1 ml). The reaction mixture was stirred at 80°C for 3 hours. The reaction mixture was lowered to room temperature, diluted with water (20ml), extracted with dichloromethane (30ml╳2), the combined organic phases were dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure to obtain the target compound (136mg, crude product, yellow solid ), used directly in the next reaction without further purification. LC-MS(ESI)m / z[M+H] + 298.2.
[0170] Step 2: Synthesis of N-hydroxy-2-((1,2,3,4-tetrahydronaphthalen-1-yl)amino)pyrimidine-5-carboxa...
Embodiment 3
[0172] Example 3; N-Hydroxy-2-(chroman-4-yl-amino)pyrimidine-5-carboxamide
[0173]
[0174] Step 1: Synthesis of ethyl 2-(chroman-4-yl-amino)pyrimidine-5-carboxylate
[0175] Ethyl 2-chloropyrimidine-5-carboxylate (200mg, 1.08mmol) and chroman-4-ylamine (240mg, 1.61mmol) were dissolved in 1,4-dioxane (5ml) , triethylamine (326 mg, 3.23 mmol) was added dropwise to the reaction mixture. After the dropwise addition, the reaction mixture was stirred at room temperature for 2 hours. The organic solvent was removed by concentration under reduced pressure, and methanol (2 ml) was added. After filtration, the filter cake was dried under reduced pressure to obtain the target compound (265 mg, yield 82.1%, white solid). LC-MS(ESI)m / z[M+H] + 300.1.
[0176] Step 2: Synthesis of N-hydroxy-2-(chroman-4-yl-amino)pyrimidine-5-carboxamide
[0177] Dissolve ethyl 2-(chroman-4-yl-amino)pyrimidine-5-carboxylate (130mg, 0.435mmol) in a mixed solvent of methanol and dichloromethane (13ml...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


